Journal of Oncology Pharmacy Practice

Article	Citations
Practical considerations in the management of patients with atrial fibrillation/flutter and hematologic malignancies	26
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant	21
Premedication strategy in cetuximab rechallenge after Grade 2 hypersensitivity reactions	19
Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients	19
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient	18
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers	17
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma	16
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients	15
A room of errors simulation to improve pharmacy operators’ knowledge of cytotoxic drug production	15
Safety and efficacy of Vitamin C, Vitamin E, and selenium supplementation in the oncology setting: A systematic review	14
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors	13
Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?	13
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)	13
Identifying health disparities in lenalidomide access	12
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice	12
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patients	12
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies	12
Initial real-world experience with ribociclib in advanced breast cancer	11
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer	11
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy	11
Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation	11
Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center	11
Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer	11
Antiandrogen therapies: Management of drug interactions with anticoagulation	10
Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment	10

CAPhO Conference 2024 Abstract Book	10
Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study	10
Estimation of financial burden of breast cancer and its effect on quality of life	10
Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products	10
Gemcitabine-associated DRESS syndrome: A case report	9
Immunotherapy “stop and go” and early discontinuation: A viable option in limited resources setting	9
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant	9
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions	9
Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review	9
Evaluating aggressiveness of end-of-life care in patients with advanced cancer: A retrospective single-center analysis	9
Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study	9
Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis	9
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review	9
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer	9
CAPhO Conference 2026 Abstract Book	9
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing	8
Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit	8
Impact of community pharmacy–based telephone follow-up on treatment completion in cancer patients receiving adjuvant chemotherapy: A retrospective observational study	8
Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant	8
Acute pancreatitis associated with pembrolizumab-induced hypertriglyceridemia	8
Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin	8
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly	8
Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy	8
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer	7
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option	7
Rapid drug desensitization to taxanes: a descriptive study from Turkey	7
Activated carbon adsorption sheets suppress volatilization of anticancer drugs excreted in urine, preventing environmental contamination and human exposure	7
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia	7
The inpatient oncology pharmacist experience in the era of temporary oncologists	7
Hepatic sinusoidal congestion associated with inotuzumab therapy in patients with B-cell acute lymphoblastic leukemia, a proposal for a new clinical entity: Calicheamicin syndrome	7
Medical marijuana in the treatment of cancer-associated symptoms	7
Safety and tolerability of adjuvant combination treatments following KEYNOTE-522 for early-stage or locally advanced breast cancer with residual disease	7
Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)	7
Risk-based analytical quality control of chemotherapy preparations: A simulation and FMECA approach	7
Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections	7
Innovation in hospital pharmacy: Modeling the installation of automated dispensing systems based on an oncology hospital experience transfer	7
Pembrolizumab related perforated appendicitis	7
Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence	7
Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome	7
Retrospective cross-sectional study of drug utilisation and expenditure of anticancer drugs at zonal referral hospital central, Tanzania	7
Hypersensitivity reaction to Abiraterone, successful desensitization protocol in prostate cancer patient	6
Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer	6
Author responseIn response to: JOPP-26–0271The French Society for Oncology Pharmacy commentary on Iannopollo M., J Oncol Pharm Pract, 2026	6
Anti-cancer drug waste disposal practices and wastewater management in hospitals: A Lebanese survey	6
Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series	6
Usefulness of hydrocortisone prophylaxis for oxaliplatin-induced hypersensitivity reactions: A retrospective study	6
Predictors of fluid overload in allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide	6
Safety and efficacy of efbemalenograstim alfa for chemotherapy-induced neutropenia: A systematic review and meta-analysis of randomized controlled trials	6
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes	6
Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies	6

Investigating effective methods of clinical pharmacy training on oncology for community pharmacists: An observational study	6
Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center	6
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar	6
Retrospective study on the efficacy and tolerability of dose modification of PD-1 and PD-L1 inhibitors in hospital-system community outpatient cancer clinics	6
Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics	6
Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments	6
Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer	6
Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution	6
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials	6
Feasibility study of an innovative simulation-based learning program in hospital oncology pharmacy: A pilot project in a faculty of pharmacy	6
Identifying risk factors of dose reduction or treatment discontinuation due to fatigue or gastrointestinal symptoms in patients receiving lenvatinib treatment for hepatocellular carcinoma	6
Real-world experience of abemaciclib for adjuvant and metastatic breast cancer	5
Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism	5
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemothera	5
Oncology pharmacy practice in Nepal: Integration, challenges, and policy directions	5
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer	5
Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience	5
Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy	5
Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer	5
Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions	5
Pharmacist's role in the management of drug–drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients	5
Cytotoxic surface contamination in hospitals: Current practices, challenges and perspectives	5
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate	5
Time-saving impact of two generation model chemotherapy compounding robots on pharmacists’ daily workflow: A long-term evaluation	5
Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide	5
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices	5
Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival, overall survival, and hypersensitivity reactions in real-world patients	5
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review	5
Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)	5
Misalignment between patient preferences and clinician expectations: Do press releases make clinicians impatient to the detriment of patients?	5
Oncology stewardship: A narrative review of principles and practices	5
Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study	5
Perceptions and prevalence of marijuana use among cancer patients managed at an outpatient department in Zimbabwe: A brief report	5
Assessment of chemotherapy dosing and regimen optimization in geriatric oncology patients diagnosed with solid organ malignancies	5
Comment on ‘risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy’	5
Cabozantinib-induced heart failure	5
An assessment of the prevalence of drug therapy problems and its associated factors among ovarian cancer patients at Kenyatta National Hospital	5
Medication errors in an oncology inpatient setting in India—Audit by clinical pharmacists	5
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies	5
Efficacy and safety of adjuvant capecitabine and pembrolizumab in early-stage triple-negative breast cancer after standard neo-/adjuvant chemotherapy: A meta-analysis of phase III studies	5
Knowledge, attitudes, and practices among oncology pharmacists on cytotoxic drug reconstitution in Sri Lanka: A cross-sectional study	4
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey	4
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance	4
Patterns and predictors of antidepressant prescribing among adults with cancer and depression in ambulatory care settings in the United States	4
Meperidine compared to morphine for rigors associated with monoclonal antibody-related infusion reactions	4
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method	4
Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer	4
The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey	4
Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study	4
Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital	4
Laryngopharyngeal dysesthesia as a possible clinical manifestation of a cytokine release reaction due to oxaliplatin	4
Overcoming language barriers to enhance pharmaceutical care: Design and validation of a pictogram-based tool for cancer patients	4
Exploring the perspective of healthcare professionals about cachexia in cancer patients; A qualitative study	4
The role of the pharmacist in the hospital discharge of cancer patients: an integrative review	4
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital	4
Overview of working conditions in pharmacy technology units: A professional evaluation in five French healthcare institution	4
Predictive risk factors associated with cancer therapy-related cardiac dysfunction: A retrospective cohort study	4
A prospective analysis of efficacy of dexamethasone-sparing antiemetic regimens in high and moderate emetogenic chemotherapy	4
Evaluating the efficacy of a premedication regimen including high-dose cetirizine in reduction of hypersensitivity reactions to paclitaxel: A retrospective cohort study	4
Hypersensitivity reactions to chemotherapy and biologics: Outcomes and safety of 927 desensitization in Mexico	4
Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India	4
Imatinib mesylate-induced acute hepatotoxicity	4
Efficacy of pegfilgrastim in preventing febrile neutropenia during DCF chemotherapy for esophageal cancer: A systematic review and meta-analysis	4
Central line-associated Rhizobium radiobacter bloodstream infection in two allogeneic hematopoietic cell transplant recipients	4
The effect of Bevacizumab treatment on the incidence of hypertension in patients with ovarian cancer: a systematic review and meta-analysis	4
Residual contamination in antineoplastic drug packaging	4
Midostaurin-Associated acute pancreatitis	4
Carboplatin dosing in obese patients	4
Chronic cannabis use in breast cancer survivors: A questionnaire study of Israeli patients	4
Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents	4
Bilateral epithelial keratopathy and punctate keratitis due to ribociclib	4
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study	4
Reduced initial Pazopanib dosing strategy for recurrent, advanced, or metastatic sarcoma: A single center experience	4
Factors associated with potentially inappropriate medications in elderly with multiple myeloma	4
Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: An integrative review	4
Vinorelbine-related tetraplegia due to severe peripheral neuropathy	4
Exploring the toxicity and clinical outcomes of doxorubicin, cyclophosphamide, and taxane-based chemotherapies in women with breast cancer in Bangladesh	4
Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics	4
Safe handling of hazardous drugs	4
Corrigendum to Audit on Oral Systemic Anti-Cancer Therapies (SACT) Adherence Using the Morisky Medication Adherence Scale (MMAS): Implications for Pharmacy Counselling	4

Concern regarding “A novel decision tree for performing risk assessments of biologics in a health-system setting”	4
Factors affecting medication adherence in patients using oral chemotherapy: A descriptive study	4
Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients	4
Therapeutic potential of phytoconstituents in oncocosmetics: A systematic review on radiodermatitis management	4
Incidence and clinical characteristics of taxane-induced peripheral neuropathy requiring treatment in patients with breast cancer	4
Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis	4
ISOPP International Symposium 2026 Abstracts	4
Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah's Witness sarcoma patient	4
Advancements in the use of nanopharmaceuticals for cancer treatment	4
CyFRASS-TR: A practical clinical predictive model for acute irinotecan-induced toxicity to enhance patient safety in solid tumor management	4
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma	3
An assessment of exposed syringe inner walls as a route of exposure from hazardous drugs	3
Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies	3
Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review	3
Immune-Mediated upper gastrointestinal toxicities reported With immune checkpoint inhibitors: An analysis of the food and drug administration adverse event reporting system (FAERS)	3
Impact of healthcare providers’ training (ISOPP-OPAB) on biosimilars use for cancer care at a university hospital in Nigeria	3
Stability of extemporaneously compounded cobimetinib oral suspensions	3
Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care	3
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy	3
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia	3
Tolerability and safety of extemporaneously prepared oral methotrexate suspension in pediatric acute lymphoblastic leukemia: Experience from a comprehensive cancer center in Jordan	3
Impact of an oncology pharmacist–led, well-developed and validated chemotherapy order template on quality of life in breast cancer patients: A randomized controlled trial	3
Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy, subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal	3
Diagnosis and management of immune checkpoint inhibitor-associated adrenal insufficiency: A single-institution experience	3
Acute pancreatitis induced by Daratumumab during multiple myeloma maintenance	3
Assessment of adverse drug reactions among acute myeloid leukaemia patients at Kenyatta National Hospital	3
One patient, one order? analyzing prescription volume in oncology opioid stewardship	3
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma	3
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer	3
Assessment of potential drug–drug interactions in hospitalized cancer patients	3
Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism	3
Oncology pharmacy staffing survey across practice settings in the United States	3
A fully validated HPLC-UV detection method associated with color variation control for the evaluation of the long term stability of calcium levofolinate solutions in polyolefin infusion bags and in po	3
Acquired angioedema late in the course of nivolumab treatment	3
Safety outcomes of teclistamab accelerated dose escalation	3
Redispensing of expensive oral anticancer medicines: A practical application	3
Development of an African paediatric oncology pharmacy curriculum: A SIOP Africa 2024 pharmacy workshop output	3
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia	3
A critical appraisal of South African oncology pharmacy standards: A comparison with international best practice standards	3
Cost analysis of closed-system transfer devices in bortezomib handling in a Brazilian cancer center	3
Burden and clinical impact of chemotherapy-induced adverse drug reactions: A prospective observational study	3
Effect of direct oral anticoagulants compared to enoxaparin on objective response to immune checkpoint inhibitors in patients with lung cancer	3
Medication review in cancer pain management: A patient safety framework for optimizing pain control and reducing medication-related harm/adverse drug events	3
Corrigendum to “Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO)”	3
Vomiting of oral medications by pediatric patients: Survey of medication re-dosing practices in pediatric oncology and stem cell transplant centers	3
Assessment of chemotherapy-related educational needs of colorectal cancer patients	3
Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center	3
A simple and inexpensive method to monitor and minimize exposure from manipulation of cytotoxic drugs	3
Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review	3
Manual versus automated chemotherapy preparation: A retrospective pharmaco-economic analysis	3
Comparative pooled analysis of targeted therapies, or immunotherapy plus chemotherapies versus conventional platinum-based therapies or single-agent immunotherapies in recurrent or metastatic head and	3
Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma	3
Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib	3
A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course	3
Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review	3
Impact of a pharmacist-led breast cancer clinic on oncology consultant workload and patient experience in a UK cancer centre	3
Contamination on the external surface of hazardous drug vials wrapped in Vial Protect Pack shrink tack labels	3
Infectious complications associated with tocilizumab following chimeric antigen receptor T-cell therapy	3
Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients	3
Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer	3
Correlation between lymphocyte counts and PD-L1 immune-related adverse events	3
Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer	3
Safe administration of temozolomide in end-stage renal disease patients	3
The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review	3
Optimizing intermittent dosing of oral small molecule inhibitors	3
Dementia as a rare neurological adverse event of Nivolumab in a patient with metastatic renal cell carcinoma	3
Real world comparison of filgrastim to filgrastim-sndz in patients with chemotherapy-induced neutropenia	3
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab	3
Overcome Daratumumab’ severe reaction with desensitization in relapsed multiple myeloma	3
A scoping review of renal function calculation methods for the dosing of carboplatin	3
Implementation of a comprehensive medication management service for radioiodine therapy patients at an oncology hospital in Rio de Janeiro	3
Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients	3
Antithrombotic and hemostatic stewardship: Evaluation of romiplostim for treatment of thrombocytopenia at a large academic medical center	3
Breast self-examination through health education from community pharmacy	3
Exploring an enhanced role of the pharmacy technician in cancer services within the uk independent sector	3
New-onset persistent hyperglycemia with initiation of brentuximab treatment	3
Oncology stewardship: Role of the pharmacists for contribution in low and middle-income countries	3
Pharmacist-led pre-infusion screening using absolute lymphocyte count and neutrophil-to-lymphocyte ratio before immune checkpoint inhibitor therapy: A practice proposal	3
Efficacy and safety of sacituzumab govitecan in hormone receptor–positive metastatic breast cancer: A systematic review and meta-analysis	3
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case	3
Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran’s healthcare administration	3
Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis	3
Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole	3
Nutrition support pharmacy practices in hospitalized cancer patients admitted to bone marrow transplant units: A 3-year retrospective analysis of clinical nutrition support pharmacists’ interventions	3
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study	3
Effects of scalp lotion containing alpha lipoic acid derivatives for chemotherapy-induced alopecia in patients with gastrointestinal cancer: A prospective cohort study	3
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma	3
A comprehensive study of adverse effects of chemotherapy on female breast cancer patients in NORI Cancer Hospital, Islamabad in a developing country	3
Drug extravasation with Enfortumab vedotin	3
Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting	3
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units	3
Rechallenges without desensitization following platinum-based chemotherapy reactions	3